2q32q33 deletion syndrome

2q32q33 deletion syndrome (also known as 2q32-q33 microdeletion syndrome) is a rare chromosomal disorder caused by a deletion of genetic material on the long arm of chromosome 2, specifically in the region spanning bands 2q32 to 2q33. This condition is classified under partial deletions of the long arm of chromosome 2 (ICD-10: Q93.5). Because the deletion can vary in size among affected individuals, the clinical presentation is somewhat variable, but characteristic features have been identified across reported cases. Key clinical features include intellectual disability of variable severity, significant speech and language delay, growth retardation, feeding difficulties in infancy, and distinctive craniofacial features. Facial dysmorphisms commonly reported include a thin upper lip, cleft or high-arched palate, a broad or prominent nasal bridge, widely spaced eyes (hypertelorism), and micrognathia. Many affected individuals also exhibit skeletal anomalies such as thin and long fingers, campodactyly, or other limb abnormalities. Behavioral issues, including features overlapping with autism spectrum disorder, have been described in some patients. Additional findings may include congenital heart defects, urogenital anomalies, and seizures, though these are not present in all cases. Most cases arise as de novo (new) deletions, meaning they occur spontaneously and are not inherited from a parent. There is no specific cure for 2q32q33 deletion syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific symptoms. This may include speech therapy, occupational therapy, physical therapy, special educational support, and medical management of associated complications such as cardiac defects or seizures. Early intervention programs are recommended to optimize developmental outcomes. Genetic counseling is advised for affected families to discuss recurrence risk and family planning.

Common questions about 2q32q33 deletion syndrome